in these studies , we showed that napa has an elimination-phase half-life that is more than twice as long as procainamide and suggested that patient compliance and arrhythmia suppression might be improved if napa were used to circumvent the inconvenience of the frequent dosing schedule that has been recommended for procainamide .
C0003811
arrhythmia
C0033216
procainamide